
As of 30-JUN-2026, promoters held 72.50% of Gufic Biosciences (0.00 pp from 31-MAR-2026), foreign institutional investors 0.46%, domestic institutions 3.68% and the public 23.36%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Promoters held 72.50% of Gufic Biosciences as of 30-JUN-2026, unchanged from 72.50% in 31-MAR-2026.
Foreign institutional investors held 0.46% of Gufic Biosciences as of 30-JUN-2026, a change of +0.04 pp from the previous quarter.
Domestic institutional investors, including mutual funds and insurers, held 3.68% of Gufic Biosciences as of 30-JUN-2026 (-0.15 pp from the previous quarter).
As of 30-JUN-2026, Gufic Biosciences' shareholders were promoters (72.50%), foreign institutional investors 0.46%, domestic institutions 3.68% and the public 23.36%, as filed with the stock exchanges.
Track GUFICBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.